Physiomics Plc (LON:PYC – Get Free Report)’s stock price rose 18.5% during trading on Wednesday . The stock traded as high as GBX 0.80 and last traded at GBX 0.77. Approximately 11,264,271 shares were traded during trading, an increase of 52% from the average daily volume of 7,425,144 shares. The stock had previously closed at GBX 0.65.
Physiomics Stock Performance
The company has a market capitalization of £3.20 million, a PE ratio of -4.70 and a beta of 0.95. The company has a 50 day simple moving average of GBX 0.50 and a 200 day simple moving average of GBX 0.42.
About Physiomics
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.
Featured Articles
- Five stocks we like better than Physiomics
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Receive News & Ratings for Physiomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physiomics and related companies with MarketBeat.com's FREE daily email newsletter.
